Abstract: The invention relates to the use of a light-gated ion channel for the manufacture of a medicament for the treatment of blindness and a method for expressing said cell specific fashion, e.g. in ON-bipolar cells, ON-ganglion cells, or AII amacrine cells.
Type:
Application
Filed:
September 13, 2012
Publication date:
January 3, 2013
Applicant:
NOVARTIS FORSCHUNGSSTIFTUNG, ZWEIGNIEDER- LASSUNG FRIEDRICH MIESCHER INSTITUTE
Inventors:
David Bayla, Pamela Sarita Laglali, Thomas Alexander Muench, Botond Roska